AIDS 347: IL-6 Blackade in Treated HIV Infection

Trial Profile

AIDS 347: IL-6 Blackade in Treated HIV Infection

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Jul 2017

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Jul 2017 Status changed from completed to active, no longer recruiting.
    • 10 Jun 2017 Biomarkers information updated
    • 30 Jan 2017 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top